Pharmacokinetics of ropivacaine following caudal analgesia in children

Paediatric Anaesthesia

Volumn 10, Issue 2, 2000, Pages 143-147

  Walid, Habre ^a,d   Fanzca, Riccardo Bergesio ^a   Fanzca, Chris Johnson ^a   Hackett, Peter ^b   Joyce, David ^c   Fanzca, Craig Sims ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b Division of Tissue Pathology   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Caudal anaesthesia; Local anaesthetics; Pharmacokinetics; Ropivacaine

Indexed keywords

ROPIVACAINE;

ANALGESIA; ARTICLE; CAUDAL ANESTHESIA; CHILD; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EPIDURAL ANESTHESIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL;

ADULT; AMIDES; ANALGESIA, EPIDURAL; ANESTHETICS, LOCAL; BIOLOGICAL AVAILABILITY; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; HALF-LIFE; HUMANS; INFANT; METABOLIC CLEARANCE RATE; SAFETY; TISSUE DISTRIBUTION;

EID: 0034061334     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2000.00454.x     Document Type: Article

References (26)

1. 1 Knudsen K, Beckman SM, Blomberg S et al. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78: 507-514.
2. 2 Baaijens PF, Gielen MJ, Vree TB et al. Bupivacaine toxicity secondary to continuous cervical epidural infusion. Case report. Reg Anesth 1995; 20: 163-168.
3. 3 Plowman AN, Bolsin S, Mather LE. Central nervous system toxicity attributable to epidural ropivacaine hydrochloride. Anaesth Intens Care 1998; 26: 204-206.
4. 4 McClure JH, Ropivacaine. Br J Annesth 1996; 76: 300-307.
5. 5 Scott DB, Lee A, Fagan D et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563-569.
6. 6 Brockway MS, Bannister J, McClure JH et al. Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31-37.
7. 7 Zaric D, Axelsson K, Nydhal PA et al. Sensory and motor blockade during epidural analgesia with 1%, 0.75% and 0.5% ropivacaine. A double blind study. Anesth Analg 1991; 72: 509-515.
8. 8 Ivani G, Mereto N, Lampugnani E et al. Ropivacaine in paediatric surgery: preliminary results. Paed Anaesth 1998; 8: 127-129.
9. 9 Ecoffey C, Desparmet J, Maury M et al. Bupivacaine in children: pharmacokinetics following caudal anaesthesia. Anesthesiology 1985; 63: 447-448.
10. 10 Mazoit JX, Denson DD, Samali K. Pharmacokinetics of bupivacaine following caudal anesthesia in infants. Anesthesiology 1988; 68: 387-389.
11. 11 Robertson J. Pediatric pain assessment: validation of a multidimensional tool. Pediatr Nurs 1993; 19: 209-213.
12. 12 Heinzel G, Woloszak R, Thomann P. Topfit, Version 2.0 Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. Stuttgart: Gustav Fischer, 1993.
13. 13 Emanuelsson BM, Persson J, Alm C et al. Systemic absorption and block after epidural injection of ropivacaine in healthy volunteers. Anesthesiology 1997; 87: 1309-1317.
14. 14 Katz JA, Bridenbaugh PO, Knarr DC et al. Pharmacodynamics and pharmacokinetics of epidural ropivacaine in humans. Anesth Analg 1990; 70: 16-21.
15. 15 Veering B, Burm A, van Kleef J et al. Epidural anesthesia with bupivacaine: effects of age on neural blockade and pharmacokinetics. Anesth Analg 1987; 66: 589-593.
16. 16 Rosenberg PH, Kytta J, Alila A. Absorption of bupivacaine, etidocaine, lignocaine and ropivacaine into n-heptane, rat sciatic nerve, and human extradural and subcutaneous fat. Br J Anaesth 1986; 58: 310-314.
17. 17 Tucker GT, Mather LE. Absorption and disposition of local anesthetics: pharmacokinetics. In: Cousins MJ, Bridenbough PO, eds. Neural Blockade in Clinical and Management of Pain. JB Philadelphia: Lippincott Company, 1980: 45-85.
18. 18 Lönnqvist PA, Westrin P, Larsson BA et al. Ropivacaine pharmacokinetics following paediatric caudal block: preliminary results. European Society for Regional Anaesthesia and European Meeting, September 1998, Geneva, Switzerland (abstract). IMRA10: 65.
19. 19 Emanuelsson BM, Persson J, Sandin S et al. Intraindividual and interindividual variability in the disposition of the local anesthetic ropivacaine in healthy subjects. Ther Drug Monit 1997; 19: 126-131.
20. 20 Emanuelsson BM, Zaric D, Nydahl PA et al. Pharmacokinetics of ropivacaine and bupivacaine during 21 hours of continuous epidural infusion in healthy male volunteers. Anesth Analg 1995; 81: 1163-1168.
21. 21 Ecoffey C, Desparmet J, Berdeaux A et al. Pharmacokinetics of lignocaine in children following caudal anaesthesia. Br J Anaesth 1984; 56: 1399-1402.
22. 22 Wilkinson GR, Lund PC. Bupivacaine levels in plasma and cerebrospinal fluid following peridural administration. Anesthesiology 1970; 33: 482-486.
23. 23 Mather LE, Tucker GT. Pharmacokinetics and biotransformation of local anesthetics. Int Anesth Clin 1978; 16: 23-51.
24. 24 Scott DA, Emanuelsson BM, Mooney PH et al. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia. Anesth Analg 1997; 85: 1322-1330.
25. 25 Eyres RL. Local anaesthetic agents in infancy. Paed Anaesth 1995; 5: 213-218.
26. 26 Alahuta S, Ala-Kokko TI. Ropivacaine: a new agent for epidural labour analgesia? Acta Anaesthesiol Scand 1998; 42: 887-889.